Skip to content
The Longevity Archive
Cerebrolysin in all countries

Legal status · United Kingdom

Is Cerebrolysin legal in the United Kingdom?

Not approvedNootropic & CNSEvidence: Moderate

No. Cerebrolysin is not an approved medicine in the United Kingdom; its classification is "Not licensed". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. Human evidence: Moderate.

Cerebrolysin in the United Kingdom at a glance

ClassificationNot licensed
MHRA approval statusNot approved by MHRA
Evidence levelModerate (research strength: Moderate)
ReviewedSep 2026

Classification and note come from the Cerebrolysin profile, checked against Medicines and Healthcare products Regulatory Agency (MHRA) listings at the reviewed date.

What this means

  • 01

    No product containing Cerebrolysin is approved by MHRA for any use in the United Kingdom, so nothing on the market is authorized for people.

  • 02

    "Research use only" is a vendor label, not a legal category that permits human use. It does not exempt a product from medicines law.

  • 03

    Importing, supplying or promoting it for human use can fall under medicines legislation in the United Kingdom. This page is general information, not legal advice.

What Cerebrolysin is

A standardized mixture of neuropeptides used clinically in many countries for stroke, dementia, and TBI.

Cerebrolysin is a preparation of low-molecular-weight neuropeptides and amino acids derived from porcine brain. Used in 30-plus countries for decades for ischemic stroke, vascular dementia, Alzheimer's disease, and TBI, its neurotrophic mixture mimics several endogenous growth factors.

Mechanism: Its neuropeptide fractions mimic neurotrophic factors such as BDNF and NGF and activate neuroprotective signaling pathways in the brain.

Regulatory history: Not FDA-approved (approved in 30+ countries)

How MHRA treats this kind of product

Licenses medicines for the UK market. A compound without a marketing authorisation is an unlicensed medicine, which can only lawfully be supplied for human use through a prescriber under the specials scheme, not sold as a research product.

The classification above is the The Longevity Archive reading of Medicines and Healthcare products Regulatory Agency listings for Cerebrolysin at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.

Cerebrolysin in other countries

Frequently asked questions

Is Cerebrolysin legal in the United Kingdom?

No. Cerebrolysin is not an approved medicine in the United Kingdom; its classification is "Not licensed". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. Human evidence: Moderate.

Can I buy Cerebrolysin in the United Kingdom?

No approved product exists to buy. In the United Kingdom Cerebrolysin is classified as "Not licensed", so there is no licensed pharmacy product. Vendors selling it "for research use only" are not selling it for human use, and that label does not change its legal status. This site does not list or recommend vendors.

Is Cerebrolysin MHRA approved?

No. In the United Kingdom Cerebrolysin is classified as "Not licensed", which is not a MHRA marketing approval. For comparison, the US FDA status is: Not FDA-approved (approved in 30+ countries). Evidence level: Moderate.

Related compounds in the United Kingdom

Full research profile

Mechanism, cited studies, FDA status and the full legal summary for Cerebrolysin live on its compound profile.

Cerebrolysin profile

This page is general information about the regulatory status of Cerebrolysin in the United Kingdom, current as of Sep 2026. It is not legal advice, and classifications change; check Medicines and Healthcare products Regulatory Agency directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.